# Phase 3 Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease

> **NCT04181593** · PHASE3 · COMPLETED · sponsor: **OmegaD LLC** · enrollment: 322 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** Omega 3 fatty acid
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04181593
- **Lead sponsor:** OmegaD LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-18
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-02-28
- **Target enrollment:** 322 (ACTUAL)
- **Last updated:** 2024-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04181593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04181593, "Phase 3 Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04181593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*